Press "Enter" to skip to content

Prostate Cancer Diagnostics and Therapy Market Share, Size, Industry Growth Rate, Development Status and Regional Trends Forecast to 2019-2024

Prostate Cancer Diagnostics and Therapy

The “Prostate Cancer Diagnostics and Therapy Market” report 2019 provides a comprehensive analysis of Prostate Cancer Diagnostics and Therapy industry by types, applications, key players and regions. It shows the Prostate Cancer Diagnostics and Therapy market 2019-2024 by production, consumption, supply, gross margin, the revenue of the industry. Additionally, the Prostate Cancer Diagnostics and Therapy market report covers the details of market size, share, and growth rate of the market with respect to regions.

Get a Sample Copy of the Report At –

Competitor Analysis:

Prostate Cancer Diagnostics and Therapy market includes the following leading manufacturers on the basis of sales, revenue, price, and gross margin.

  • Ipsen SA
  • Bayer AG
  • Astellas Pharma Inc.
  • Abbvie Inc.
  • Dendreon Pharmaceuticals LLC
  • AstraZeneca PLC
  • Sanofi
  • Aventis
  • Tolmar Inc.
  • Koninklijke Philips NV
  • Hologic Inc.

    Market Overview:

  • The prostate cancer diagnostics and therapy market is expected to register a CAGR of nearly 6.1% during the forecast period, 2019-2024.
  • – The major factor driving the growth of the market studied is aging population and high prevalence rate of prostate cancer. Prostate cancer is the second most common type of cancer in male population. About 80% of men who reach 80 years of age are diagnosed with it.
  • – As per the estimates provided by the American Cancer Society, in 2018, the United States is expected to witness over 164,690 new cases of prostate cancer, with over 29,430 related deaths. Nearly 60% of the total prostate cancer cases diagnosed are among men aged 65 years or older. One in every nine men is expected to be diagnosed with prostate cancer during his lifetime.
  • – In addition, according to the United States Census Bureau’s Statistics, the total number of people aged 65 and older exceeds 50 million as of 2017, and the number of elderly is projected to increase by almost 18 million during 2020-2030. The number of people aged 85 and older is expected to triple from an estimated 6 million of today to nearly 20 million, by 2060. The risk of developing prostate cancer increases significantly with age, and rise in geriatric population is one of the leading factors that contribute to the expansion of the mar

    Prostate Cancer Diagnostics and Therapy market report presents in-depth analysis regarding the development, current trends, industry policies and regulations implemented in each of the geographical region. It includes analysis of upstream raw materials, downstream demand, and current market dynamics. Furthermore, the Prostate Cancer Diagnostics and Therapy market report provides in-depth insight of Prostate Cancer Diagnostics and Therapy industry during 2019-2024.

    Scope of the Report:

  • The prostate gland is located in the pelvis, below the bladder and in front of the rectum. Prostate cancer begins when normal cells in the prostate begin to multiply uncontrollably. The scope of the study is limited to revenue generated by various diagnostic and therapeutic products used in the management of benign prostatic hyperplasia, prostatic adenocarcinoma, and small cell carcinoma, among other types of prostate cancer.

    Inquire or Share Your Questions If Any Before the Purchasing This Report –

    Key Market Trends:

    The Prostate-specific Antigen (PSA) Testing Segment is Expected to Grow at Rapid Pace.

    Prostate-specific Antigen (PSA) is a protein produced by prostate cells. Therefore, the PSA test is performed to diagnose prostate cancer (PCa) in men and for follow-up post treatment to check if the cancer relapses. PSA testing is an important tool for detecting prostate cancer, which measures the level of PSA in a man’s blood. Medicare and several private insurers provide coverage for an annual PSA test for all Medicare-eligible men aged 50 and older. The PSA testing is gaining popularity among clinicians and hospitals, owing to the increasing number of people being affected by prostate cancer. It has more market value in the countries with high prevalence rate (Western) and low prevalence rate (Asian), as PSA is used globally for the early detection/screening of prostate cancer.

    PSA testing is anticipated to reduce the likelihood of death from prostate cancer. Refinements of the prostate-specific antigen (PSA) test have been developed to reduce the number of false positive results. Therefore, due to the rising prevalence of prostate cancer, the market is expected to witness high growth rate, over the forecast period.

    United States is Expected to Retain the Largest Market Share During the Period of Forecast.

    Prostate cancer is considered as one of the most common cancers among American men, and more than 60% of all prostate cancers are diagnosed in men older than 65. According to the American Cancer Society’s, 2019, there are about 174,650 new cases of prostate cancer accounting for 31,620 deaths. Hence, it is considered to have an early diagnosis of the condition. In case of the treatment, the early stages of prostate cancer are treated by radiation therapy and for the late stages, where it has spread beyond the prostate gland, hormone therapy, chemotherapy, and or immunotherapy treatments, are recommended. In the case of benign prostatic hyperplasia (BPH), resectoscopy is the major treatment procedure. Zytiga and Xtandi are the major therapeutics that are used for treatment. Zytiga is approved for the treatment of metastatic castration-resistant prostate cancer (mCRPC). With promising pipeline drugs, such as Apalutamide, the market of therapeutics is expected to increase.

    Reasons to Buy Prostate Cancer Diagnostics and Therapy Market Report:

    • Analysis of Prostate Cancer Diagnostics and Therapy market including revenues, future growth, market outlook
    • Historical data and forecast of Prostate Cancer Diagnostics and Therapy industry
    • Prostate Cancer Diagnostics and Therapy market report covers regional analysis including growth estimates
    • To analyze the end user markets including growth estimates
    • Profiles on laboratory balance including products, sales/revenues, and market position
    • Includes Prostate Cancer Diagnostics and Therapy market structure, market drivers, opportunities, and restraints.

    Purchase this Report (Price 4250 USD for a Single-User License) –

    Prostate Cancer Diagnostics and Therapy Market Report Covers the Following Questions:

    • What trends, challenges and barriers are influencing its growth?
    • What is the and regional outlook for Prostate Cancer Diagnostics and Therapy market?
    • Who are the key players, and what are their strategies?
    • What is the status of Prostate Cancer Diagnostics and Therapy status worldwide?
    • What are the Prostate Cancer Diagnostics and Therapy market challenges to market growth? 
    • What are the Prostate Cancer Diagnostics and Therapy market challenges to market growth? 
    • What are the types and applications of Prostate Cancer Diagnostics and Therapy ?
    • What is the market share of each type and application? 

    Detailed TOC of Prostate Cancer Diagnostics and Therapy Market 2019-2024:

    1.1 Study Deliverables
    1.2 Study Assumptions
    1.3 Scope of the Study



    4.1 Market Overview
    4.2 Market Drivers
    4.2.1 Rising Aging Population and High Prevalence Rate of Prostate Cancer
    4.2.2 Innovation in Drugs and Developments in Genomics and Proteomics
    4.2.3 Increasing Government Initiatives for Cancer Awareness
    4.3 Market Restraints
    4.3.1 High Cost of Prostate Cancer Drugs
    4.3.2 Low Success Rate of Clinical Trials
    4.4 Porter’s Five Force Analysis
    4.4.1 Threat of New Entrants
    4.4.2 Bargaining Power of Buyers/Consumers
    4.4.3 Bargaining Power of Suppliers
    4.4.4 Threat of Substitute Products
    4.4.5 Intensity of Competitive Rivalry

    5.1 By Type
    5.1.1 Benign Prostatic Hyperplasia
    5.1.2 Prostatic Adenocarcinoma
    5.1.3 Small Cell Carcinoma
    5.1.4 Other Types
    5.2 By Modality
    5.2.1 Diagnosis Tissue Biopsy Transrectal Ultrasound Clinical Laboratory Examination Prostate-specific Antigen Testing Urine Testing Diagnostic Imaging
    5.2.2 Treatment Surgery Radiation Therapy Therapeutics Hormone Therapy Chemotherapy Other Treatments
    5.3 Geography
    5.3.1 North America United States Canada Mexico
    5.3.2 Europe Germany United Kingdom France Italy Spain Rest of Europe
    5.3.3 Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific
    5.3.4 Middle East & Africa GCC South Africa Rest of Middle East & Africa
    5.3.5 South America Brazil Argentina Rest of South America

    6.1 Company Profiles
    6.1.1 Ipsen SA
    6.1.2 Bayer AG
    6.1.3 Astellas Pharma Inc.
    6.1.4 Abbvie Inc.
    6.1.5 Dendreon Pharmaceuticals LLC
    6.1.6 AstraZeneca PLC
    6.1.7 Sanofi-Aventis
    6.1.8 Tolmar Inc.
    6.1.9 Koninklijke Philips NV
    6.1.10 Hologic Inc.



    Contact Us:

    Name: Ajay More

    Phone: US +14242530807/ UK +44 20 3239 8187

    Email: [email protected]

    Our Other Reports:

    Global Tapioca Starch Market 2019 by Major Companies, Regional Analysis, Recent Development, Future Prospects Forecast to 2023

    Shock Absorbers Market 2019 Offers Newest Industry Data, Industry Future Trends, Sales, Revenue, Growth Rate by Types and Applications Forecast till 2023

    Cetearyl Alcohol Market 2019 Outlook by Import, Export, Consumption and Consumption Value by Major Countries and Key Players Forecast to 2023

    Global Linolenic Acid Market 2019 Industry Size and Share Evolution to 2023 by Growth Insight, Key Development, Trends and Forecast by